Bimekizumab Efficacy and Safety in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 3-year Results from BE BRIGHT, A Multicenter, Open- Label, Phase 3 Study
This trail was presented on March 10 2024 at the American Academy of Dermatology (AAD) Annual Meeting 2024 held in San Diego between March 8-12,